Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine Preconditioning in Pediatric Cardiac Surgery
NCT00881686Phase 2Completed
- Sponsor
- Xijing Hospital
- Start
- Jun 2008
- Primary completion
- Dec 2008
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2 trial of adenosine in myocardial reperfusion injury, sponsored by Xijing Hospital. Primary endpoint: All-cause mortality at 30 days. Started Jun 2008; status: completed.
02
Drugs
adenosine
03
Conditions
myocardial reperfusion injury
Beyond the preview
Go deeper on NCT00881686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00881686.